{"url_path":"/sec/til/8-k/2026-05-15/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/1789769/0001789769-26-000044-index.html","accession_number":"0001789769-26-000044","cik":"0001789769","ticker":"TIL","issuer_name":"Instil Bio, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1789769/0001789769-26-000044-index.html","primary_entity_key":"0001789769","primary_entity_name":"Instil Bio, Inc."},"word_count":93,"has_tables":true,"body_markdown":"Item 9.01 Financial Statements and Exhibits.\n\n \n\n(d)\n\nExhibits\n\n \n\nExhibit No.\n\n \n\nDescription\n\n99.1\n\n \n\n[Press release, dated May 15, 2026](q1-26er.htm)\n\n104\n\nThe cover page of this report has been formatted in Inline XBRL.\n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n\n \n\nInstil Bio, Inc.\n\nDated: May 15, 2026\n\n \n\n \n\nBy:\n\n \n\n/s/ Sandeep Laumas, M.D.\n\n \n\n \n\n \n\nSandeep Laumas, M.D.\n\n \n\n \n\n \n\nChief Financial Officer and Chief Business Officer\n\n(Principal Financial Officer and Principal Accounting Officer)"}